Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients

Journal of Antimicrobial Chemotherapy

Volumn 53, Issue 3, 2004, Pages 540-543

  López Vélez, Rogelio ^a   Videla, Sebastián ^b   Márquez, Manuel ^c   Boix, Vicente ^d   Jiménez Mejías, Manuel E ^e   Górgolas, Miguel ^f   Arribas, José R ^g   Salas, Ana ^h   Laguna, Fernando ^g   Sust, Mariano ^b   Cañavate, Carmen ⁱ   Alvar, Jorge ⁱ   Alteés, Jordi ^j   Antunes, Francisco ^k   Buira, Elizabeth ^l   García, Almudena ^g   Gatell, Joseph M ^l   Gavilán, Fuensanta ^m   Marrero, Jorge ^f   Prados, Lola ^e   Pintado, Vicente ^a   Perez Molina, Jose ⁿ   Pulido, Federico ^o   Quereda, Carmen ^a   Rivero, Antonio ^m   Roca, Víctor ^p   Rubio, Rafael ^o   Santos, Jesús ^c   Sanz, Jesús ^q   Serrano, Oscar ^g   Sirera, Guillem ^r   Tortajada, Cecilia ^l   Torre Cisneros, Julián ^m   Valencia, Eulalia ^g   Vidal, Elisa ^m   Chicharro, Carmen ^s   Cruz, Ismael ^s   Morales, Miguel A ^s   García, Emilia ^s   Gutierrez, Beatriz ^s   Casals, Soledad ^b   García, Carmen ^b   Sans, Artur ^b   Puyada, Alberto ^b   Tolrà, Ignasi ^b   more..

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b Laboratorios Dr Esteve SA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^e Hospital Virgerndel Rocío   (Spain)

^f Hospital UniversitarioFundación Jiménez Díaz   (Spain)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^h HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

ⁱ INSTITUTO DE SALUD CARLOS III   (Spain)

^j Hospital Comarcal de L'Alt Penedes   (Spain)

^k HOSPITAL DE SANTA MARIA   (Portugal)

^l HOSPITAL CLÍNIC   (Spain)

^m HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁿ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^o HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^p HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^q HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^r HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^s INSTITUTO DE SALUD CARLOS III   (Spain)

more..

Author keywords

Amphotericin B; Clinical trial with blinded centralized randomization; HIV; Leishmaniasis

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIRETROVIRUS AGENT; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; TRIACYLGLYCEROL;

ADULT; ANKYLOSIS; ARTICLE; ASTHENIA; BONE MARROW BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DEPRESSION; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISTAXIS; FATIGUE; FEMALE; FEVER; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERBILIRUBINEMIA; HYPERTRIGLYCERIDEMIA; INFLUENZA; KIDNEY COLIC; LEISHMANIA; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUTROPENIA; PORTUGAL; PROPHYLAXIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RELAPSE; RESPIRATORY TRACT DISEASE; SECONDARY PREVENTION; SHIVERING; SPAIN; SPLENOMEGALY; THRUSH; TRAFFIC ACCIDENT; TREMOR; VISCERAL LEISHMANIASIS; VOMITING;

ADULT; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HIV INFECTIONS; HUMANS; LEISHMANIASIS, VISCERAL; MALE; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS;

EID: 12144285962     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh084     Document Type: Article

References (9)

1. López-Vélez, R., Pérez Molina, J. A., Guerrero, A. et al. (1998). Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmaniasis in an area of Madrid, Spain. American Journal of Tropical Medicine and Hygiene 58, 436-43.
2. Janoff, A. S., Perkins, W. R., Saletan, S. L. et al. (1993). Amphotericin B lipid complex (ABLC™): A molecular rationale for the attenuation of amphotericin B related toxicities. Journal of Liposome Research 3, 451-71.
3. Sundar, S., Agrawal, N. K., Sinha, P. R. et al. (1997). Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Annals of Internal Medicine 127, 133-7.
4. Casado, J. L., López-Vélez, R., Pintado, V. et al. (2001). Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy. European Journal of Clinical Microbiology and Infectious Diseases 20, 202-5.
5. Laguna, F., Adrados, M., Alvar, J. et al. (1997). Visceral leishmaniasis in patients infected with the human immunodeficiency virus. European Journal of Clinical Microbiology and Infectious Diseases 16, 898-903.
6. Lazanas, M. C., Tsekes, G. A., Papandreou S. et al. (1993). Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS 7, 1018-19.
7. Lafeuillade, A., Chaffanjon, P., Delbeke, E. et al. (1992). Maintenance itraconazole for visceral leishmaniasis in HIV infection. American Journal of Medicine 92, 449.
8. Ribera, E., Ocaña, I., de Otero, J. et al. (1996). Prophylaxis of visceral leishmaniasis in human immunodeficiency virus-infected patients. American Journal of Medicine 100, 496-501.
9. López-Vélez, R., Casado, J. L. & Pintado, V. (2001). Decline of a visceral leishmaniasis epidemic in HIV-infected patients after the introduction of highly active antiretroviral therapy (HAART). Clinical Microbiology and Infection 7, 394-5.